Gaechter Pascal, Ebrahimi Fahim, Kutz Alexander, Szinnai Gabor
Pediatric Endocrinology and Diabetology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.
Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
EClinicalMedicine. 2025 Jan 16;80:103062. doi: 10.1016/j.eclinm.2024.103062. eCollection 2025 Feb.
People with Down syndrome suffer from multiple associated diseases. However, knowledge on rates and causes of hospitalizations is limited.
This population-based cohort study used national hospital claims data in Switzerland between January 1, 2012 and December 31, 2020. Included were hospitalizations of people aged 0-90 years. People with Down syndrome were identified using ICD-10-GM code Q90 and were compared to the general population. The primary outcome was the hospitalization rate. Secondary outcomes were the primary reasons for hospitalizations, secondary diagnoses, and in-hospital outcomes. Analyses were stratified by three age groups: neonates and infants (0-12 months), children and adolescents (1-17 years), and adults (18-90 years). We calculated incidence rates, risk ratios (RR), and regression coefficients with corresponding 95% confidence intervals (CI).
Among 9,992,538 hospitalizations, 5697 were identified for people with Down syndrome. Hospitalization rate for people with Down syndrome was highest in the first two years of life. In the total general population, it was highest in adults beyond 60 years. Primary reasons for hospitalization among people with Down syndrome were classified as diagnoses of the circulatory system (neonates and infants: RR 13.3 [95% CI 12.0-14.6], children and adolescents: RR 3.3 [95% CI 2.7-3.9]), and infectious diseases (adults: RR 4.0 [95% CI 3.7-4.2]). At birth, individuals with Down syndrome typically had an average of six diagnoses, a number that the general population reaches, on average, by the age of 69. People with Down syndrome experienced worse in-hospital outcomes, including longer stays in both the hospital and intensive care unit by a factor of 1.7 and a higher all-cause in-hospital mortality by an overall rate difference of 1.9%.
The findings underscore the medical complexity of hospitalized people with Down syndrome and emphasize the need for a comprehensive, age-inclusive approach to improve in-hospital outcomes and anticipate emergency hospitalizations across age groups.
Kantonsspital Aarau AG.
唐氏综合征患者患有多种相关疾病。然而,关于住院率和住院原因的了解有限。
这项基于人群的队列研究使用了瑞士2012年1月1日至2020年12月31日期间的全国医院索赔数据。纳入的是0至90岁人群的住院病例。使用国际疾病分类第10版德国修订本(ICD - 10 - GM)编码Q90识别唐氏综合征患者,并与普通人群进行比较。主要结局是住院率。次要结局包括住院的主要原因、次要诊断和住院结局。分析按三个年龄组分层:新生儿和婴儿(0 - 12个月)、儿童和青少年(1 - 17岁)以及成年人(18 - 90岁)。我们计算了发病率、风险比(RR)和回归系数以及相应的95%置信区间(CI)。
在9992538例住院病例中,识别出5697例唐氏综合征患者。唐氏综合征患者的住院率在生命的头两年最高。在整个普通人群中,60岁以上成年人的住院率最高。唐氏综合征患者住院的主要原因归类为循环系统疾病(新生儿和婴儿:RR 13.3 [95% CI 12.0 - 14.6],儿童和青少年:RR 3.3 [95% CI 2.7 - 3.9])以及传染病(成年人:RR 4.0 [95% CI 3.7 - 4.2])。出生时,唐氏综合征患者平均有六个诊断,而普通人群平均到69岁时才达到这个数量。唐氏综合征患者的住院结局较差,包括在医院和重症监护病房的住院时间延长1.7倍,全因住院死亡率总体高出1.9%。
这些发现强调了唐氏综合征住院患者的医疗复杂性,并强调需要一种全面的、涵盖所有年龄段的方法来改善住院结局并预测各年龄组的急诊住院情况。
阿劳州立医院股份公司(Kantonsspital Aarau AG)